Browse SNAPIN

Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Membrane Peripheral membrane protein Cytoplasmic side Cytoplasm, cytosol Cytoplasm, perinuclear region Golgi apparatus membrane Lysosome membrane Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane Note=Colocalizes with NANOS1 and PUM2 in the perinuclear region of germ cells.
Domain PF14712 Snapin/Pallidin
Function

Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Plays a role in intracellular vesicle trafficking and synaptic vesicle recycling. May modulate a step between vesicle priming, fusion and calcium-dependent neurotransmitter release through its ability to potentiate the interaction of synaptotagmin with the SNAREs and the plasma-membrane-associated protein SNAP25. Its phosphorylation state influences exocytotic protein interactions and may regulate synaptic vesicle exocytosis. May also have a role in the mechanisms of SNARE-mediated membrane fusion in non-neuronal cells (PubMed:17182842, PubMed:18167355). As part of the BORC complex may play a role in lysosomes movement and localization at the cell periphery. Associated with the cytosolic face of lysosomes, the BORC complex may recruit ARL8B and couple lysosomes to microtubule plus-end-directed kinesin motor (PubMed:25898167).

> Gene Ontology
 
Biological Process GO:0001505 regulation of neurotransmitter levels
GO:0006836 neurotransmitter transport
GO:0006885 regulation of pH
GO:0006887 exocytosis
GO:0006906 vesicle fusion
GO:0006914 autophagy
GO:0007018 microtubule-based movement
GO:0007033 vacuole organization
GO:0007034 vacuolar transport
GO:0007035 vacuolar acidification
GO:0007040 lysosome organization
GO:0007041 lysosomal transport
GO:0007042 lysosomal lumen acidification
GO:0007269 neurotransmitter secretion
GO:0008088 axo-dendritic transport
GO:0008089 anterograde axonal transport
GO:0008090 retrograde axonal transport
GO:0008333 endosome to lysosome transport
GO:0010721 negative regulation of cell development
GO:0010970 transport along microtubule
GO:0010975 regulation of neuron projection development
GO:0010977 negative regulation of neuron projection development
GO:0016050 vesicle organization
GO:0016079 synaptic vesicle exocytosis
GO:0016188 synaptic vesicle maturation
GO:0016197 endosomal transport
GO:0016236 macroautophagy
GO:0017156 calcium ion regulated exocytosis
GO:0021700 developmental maturation
GO:0023061 signal release
GO:0030004 cellular monovalent inorganic cation homeostasis
GO:0030641 regulation of cellular pH
GO:0030705 cytoskeleton-dependent intracellular transport
GO:0031345 negative regulation of cell projection organization
GO:0031503 protein complex localization
GO:0031629 synaptic vesicle fusion to presynaptic active zone membrane
GO:0032418 lysosome localization
GO:0032438 melanosome organization
GO:0033059 cellular pigmentation
GO:0034629 cellular protein complex localization
GO:0035751 regulation of lysosomal lumen pH
GO:0043393 regulation of protein binding
GO:0043473 pigmentation
GO:0044801 single-organism membrane fusion
GO:0045026 plasma membrane fusion
GO:0045055 regulated exocytosis
GO:0045324 late endosome to vacuole transport
GO:0045665 negative regulation of neuron differentiation
GO:0045851 pH reduction
GO:0047496 vesicle transport along microtubule
GO:0048284 organelle fusion
GO:0048489 synaptic vesicle transport
GO:0048490 anterograde synaptic vesicle transport
GO:0048753 pigment granule organization
GO:0050768 negative regulation of neurogenesis
GO:0050808 synapse organization
GO:0051098 regulation of binding
GO:0051452 intracellular pH reduction
GO:0051453 regulation of intracellular pH
GO:0051604 protein maturation
GO:0051640 organelle localization
GO:0051648 vesicle localization
GO:0051650 establishment of vesicle localization
GO:0051656 establishment of organelle localization
GO:0051961 negative regulation of nervous system development
GO:0055067 monovalent inorganic cation homeostasis
GO:0061025 membrane fusion
GO:0072384 organelle transport along microtubule
GO:0072553 terminal button organization
GO:0080171 lytic vacuole organization
GO:0090174 organelle membrane fusion
GO:0097352 autophagosome maturation
GO:0097479 synaptic vesicle localization
GO:0097480 establishment of synaptic vesicle localization
GO:0097576 vacuole fusion
GO:0098930 axonal transport
GO:0099003 vesicle-mediated transport in synapse
GO:0099500 vesicle fusion to plasma membrane
GO:0099504 synaptic vesicle cycle
GO:0099514 synaptic vesicle cytoskeletal transport
GO:0099517 synaptic vesicle transport along microtubule
GO:0099518 vesicle cytoskeletal trafficking
GO:0099531 presynaptic process involved in chemical synaptic transmission
GO:0099643 signal release from synapse
GO:1902774 late endosome to lysosome transport
GO:1902822 regulation of late endosome to lysosome transport
GO:1902824 positive regulation of late endosome to lysosome transport
GO:1903335 regulation of vacuolar transport
GO:1903337 positive regulation of vacuolar transport
Molecular Function GO:0000149 SNARE binding
Cellular Component GO:0005765 lysosomal membrane
GO:0008021 synaptic vesicle
GO:0030133 transport vesicle
GO:0030141 secretory granule
GO:0030424 axon
GO:0030658 transport vesicle membrane
GO:0030659 cytoplasmic vesicle membrane
GO:0030672 synaptic vesicle membrane
GO:0031082 BLOC complex
GO:0031083 BLOC-1 complex
GO:0032838 cell projection cytoplasm
GO:0033267 axon part
GO:0044445 cytosolic part
GO:0070382 exocytic vesicle
GO:0098793 presynapse
GO:0098852 lytic vacuole membrane
GO:0099078 BORC complex
GO:0099501 exocytic vesicle membrane
GO:0099503 secretory vesicle
GO:0099568 cytoplasmic region
GO:1904115 axon cytoplasm
> KEGG and Reactome Pathway
 
KEGG -
Reactome R-HSA-421837: Clathrin derived vesicle budding
R-HSA-432722: Golgi Associated Vesicle Biogenesis
R-HSA-199991: Membrane Trafficking
R-HSA-5653656: Vesicle-mediated transport
R-HSA-199992: trans-Golgi Network Vesicle Budding
Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between SNAPIN and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 

There is no record.

Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of SNAPIN in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell logFC: -2.40; FDR: 0.02000 Resistant to T cell-mediated killing
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NS NA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR NA/NS NA/NS
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NS NA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NS NA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NS NA/NS
24476824shRNAmelanomaB16Primary screen NA/NS NA/NS
24476824shRNAmelanomaB16Secondary screen NA/NS NA/NS
Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of SNAPIN in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)1412-0.0830.628
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)65-0.10.968
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)87-0.070.969
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160.5170.179
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590.4060.727
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470.660.65
729033130MelanomaallAnti-PD-1 (nivolumab) 2623-0.1480.627
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 1511-0.3190.812
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 1112-0.0010.999
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 48-0.0870.964
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 28-0.1790.952
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 682300.1480.00958
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of SNAPIN in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14170001
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 1030001
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 4140001
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 27730001
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 0140001
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 27590001
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)21174.804.81
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)860001
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)13117.707.71
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160001
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590001
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470001
1329033130MelanomaallAnti-PD-1 (nivolumab) 38270001
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 22130001
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 16140001
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 11130001
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 5120001
Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of SNAPIN. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of SNAPIN. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by SNAPIN.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of SNAPIN. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of SNAPIN expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between SNAPIN and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolSNAPIN
NameSNAP-associated protein
Aliases BLOC1S7; BORCS3; SNAP-25-binding protein; biogenesis of lysosomal organelles complex-1, subunit 7; SNAPAP; B ......
Chromosomal Location1q22
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting SNAPIN collected from DrugBank database.
> Drugs from DrugBank database
 

There is no record.